Amphastar Pharmaceuticals, Inc. AMPH

Full chart Compare
Set alert

Price alert · AMPH

All alert types
27.12 USD +0.09 (+0.33%)

At closeNov 3, 2026, 4:01 PM EST

27.12 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

26.85 Day range 27.39
16.65 52-week range 29.52
YTD
+1.27%
1 year
+7.19%

Revenue & Expenses

Revenue by
United States → Revenue: $681.42MRevenue → Gross Profit: $356.06MGross Profit → Net Income: $98.09MGross Profit → Selling, General & Admin: $129.81MGross Profit → Research & Development: $85.84MRevenue → Cost of Revenue: $363.83MGross Profit → Other Expenses: $16.78MGross Profit → Income Tax: $25.53MFrance → Revenue: $35.28MChina → Revenue: $3.18MGross Profit$356.06MCost of Revenue$363.83MNet Income$98.09MSelling, General & Admin$129.81MResearch & Development$85.84MOther Expenses$16.78MIncome Tax$25.53MRevenue$719.89MUnited States$681.42MFrance$35.28MChina$3.18M

Latest period ending Dec 31, 2025 · select a line to chart its full history

AMPH annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
719.89M731.97M644.39M498.99M437.77M
356.06M373.86M351.12M248.86M199.74M
140.40M205.42M196.99M107.50M69.89M
98.09M159.52M137.54M91.39M62.12M
2.033.062.601.741.25
AMPH annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
170.41M151.84M144.53M156.33M126.59M
1.63B1.58B1.51B741.99M671.53M
840.49M845.17M873.49M213.33M226.01M
656.00M650.55M623.64M102.58M104.66M
788.80M732.30M639.42M528.66M445.52M
AMPH annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
156.12M213.39M183.50M89.18M97.99M
-70.33M-124.93M-649.12M-32.78M-28.67M
-67.42M-80.95M454.09M-26.44M-37.02M
-34.88M-41.04M-38.17M-23.61M-27.46M
18.57M7.31M-11.80M29.75M32.08M